| Entry |
|
|---|
| Name |
Adriforant (USAN/INN) |
|---|
| Formula |
C13H22N6
|
|---|
| Exact mass |
262.1906
|
|---|
| Mol weight |
262.35
|
|---|
| Structure |
|
|---|
| Efficacy |
Antipsoriatic |
|---|
| Comment |
Treatment of psoriasis and atopic dermatitis
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH4
D11819 Adriforant (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 N5x N 13.0900 -18.4800
2 C8y C 13.0900 -17.0800
3 C8x C 14.2800 -16.3800
4 C8y C 15.5400 -17.0800
5 N5x N 15.5400 -18.4800
6 C8y C 14.2800 -19.1800
7 N1a N 14.2800 -20.5800
8 N1b N 16.7300 -16.3800
9 C1b C 17.9200 -17.0800
10 C1y C 19.1100 -16.3800
11 N1y N 11.9000 -16.3800
12 C1x C 10.6400 -16.9400
13 C1x C 9.6600 -15.8900
14 C1y C 10.3600 -14.7000
15 C1x C 11.7600 -14.9800
16 N1b N 9.8000 -13.4400
17 C1a C 8.4000 -13.3000
18 C1x C 20.5100 -16.3800
19 C1x C 19.8100 -15.1900
BOND 21
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 4 8 1
9 8 9 1
10 9 10 1
11 2 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 11 15 1
17 14 16 1
18 16 17 1
19 10 18 1
20 18 19 1
21 19 10 1
|
|---|
